April 8, 2021 – Medtronic plc (Minneapolis, MN) has announced its ongoing commitment to health equity for people of color living with diabetes. The company committed investments in partnerships with the American Diabetes Association (ADA) and T1D Exchange, as well as additional research efforts, to better understand and address these disparities. Details of each partnership, as well as additional activities conducted by Medtronic, including:
- Health Equity Now Initiative with ADA
- Reducing Inequities in Diabetes Management with T1D Exchange
- Investigator-Initiated Research: “A Feasibility Study of Novel Combined Intervention for Blood Glucose Management in Type 1 Diabetes (T1D) Among African-American Patients”